William G Whitford,
Life Science Strategic Solutions Leader,
DPS Group
Bill Whitford is Life Science Strategic Solutions Leader at DPS Group. Formerly Strategic Solutions Leader, BioProcess, Cytiva, formerly GE Healthcare Life Sciences in Logan, UT with over 20 years’ experience in biotechnology product and process development. He joined the company 16 years ago as a team leader in R&D developing products supporting biomass expansion, protein expression and virus secretion in mammalian and invertebrate cell lines. Products he has commercialized include defined and animal product-free hybridoma media, fed-batch supplements, and aqueous lipid dispersions. An invited lecturer at international conferences, Bill has published over 250 articles, book chapters and patents in several areas of bioproduction. He now enjoys such industry activities as serving on the editorial advisory board for BioProcess International.
Digital Biomanufacturing and Advanced Bioinks Enable 3D/4D Bioprinting
Friday, 17 March 2017 at 11:00
Add to Calendar ▼2017-03-17 11:00:002017-03-17 12:00:00Europe/LondonDigital Biomanufacturing and Advanced Bioinks Enable 3D/4D BioprintingSELECTBIOenquiries@selectbiosciences.com
Synergies in bioprinting are appearing from individual researchers focusing on divergent aspects of the technology. Many are now evolving from simple mono-dimensional operations to model-controlled multi-material, interpenetrating networks using multi-modal deposition techniques. Bioinks are being designed to address numerous critical process parameters. These bioink parameters include such structural material characteristics as supramolecular chemistries, biological considerations as cell nutritional requirements and physical properties as plastic flow and hydrodynamic force. These factors, combined with advances in artificial intelligence, automation and robotics, are evolving our concept of bioprinting in general. Such digital biomanufacturing concepts as increased monitoring, data handling, connectivity, computer power, control algorithms and automation promise new advances including real-time optimization of the printing process. The IIoT, Big Data and the Cloud complement such initiatives as Lean PPD, SCADA and DCS to advance our process control capabilities. In digitally biomanufactured tissue constructs both the cellular constructs and architectural design for any necessary vascular component in is being addressed. More and higher quality data are being collected and analysis is becoming richer. This information management and model generation is now describing a “process network” promising more efficient use of both locally and imported raw data and supporting accelerated decision making. Soon we will see real-time optimization of the immediate bioprinting bioprocess based on such high value criteria as instantaneous progress assessment and comparison to previous activities.
Add to Calendar ▼2017-03-16 00:00:002017-03-17 00:00:00Europe/LondonBioMEMS, Microfluidics and Biofabrication: Technologies and ApplicationsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2017-03-17 11:00:002017-03-17 12:00:00Europe/LondonDigital Biomanufacturing and Advanced Bioinks Enable 3D/4D BioprintingSELECTBIOenquiries@selectbiosciences.com
 2_150x75.png)
